Anne van der Waaij

Appearances

ULTRASOUND-GUIDED NEEDLE BIOPSY FLUORESCENCE SPECTROSCOPY WITH QUANTITATIVE FLUORESCENCE ENDOSCOPY FOR RESPONSE MONITORING IN PATIENTS WITH ESOPHAGEAL CANCER AFTER NEOADJUVANT CHEMORADIOTHERAPY USING BEVACIZUMAB-800CW
Date
May 8, 2023
BACKGROUND: Using EsoCheck (EC), a non-endoscopic balloon device for sampling the distal esophagus, coupled with EsoGuard (EG), a DNA based testing screening for Barrett’s esophagus (BE), we have previously reported high sensitivity and specificity for detection of BE among patients with known BE c…
Presenter
Iris Schmidt
Speakers
Anne van der Waaij
Gursah Kats-Ugurlu
Frederieke Dijkstra
Jan Willem Haveman
Boudewijn van Etten
Dominic Robinson
Wouter Nagengast
FLUORESCENTLY LABELLED VEDOLIZUMAB IDENTIFIED MACROSCOPIC AND MICROSCOPIC MUCOSAL DRUG DISTRIBUTION AND TARGET CELLS IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE
Date
May 9, 2023
BACKGROUND: Biological treatment in inflammatory bowel disease (IBD) patients is currently hampered by high non-response rates. To enhance personalized medicine and predict response to biological therapeutics such as vedolizumab, the working mechanism should be elucidated…
Speakers
Ruben Gabriëls
Matthijs Linssen
Pia Volkmer
Michael Dobosz
Dominic Robinson
Marcela Hermoso
Arend Karrenbeld
Eleonora Festen
Gerard Dijkstra
Gursah Kats-Ugurlu
Wouter Nagengast
Presenter
Anne van der Waaij